Bright Minds Biosciences (DRUG) Cash & Equivalents (2020 - 2026)
Bright Minds Biosciences (DRUG) reported Cash & Equivalents of $222.54 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 500.0% from $37.09 million a year earlier but down 1.5% from the prior quarter.
Powered by 
Analysis
Bright Minds Biosciences (DRUG) Cash & Equivalents (2020 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Bright Minds Biosciences posted Cash & Equivalents of $59.32 million.
- Cash & Equivalents has a five-year compound annual growth rate of 151.0% (FY2020 to FY2025).
- By fiscal year, Cash & Equivalents came in at $4.21 million in FY2024 (-16.0%), $5 million in FY2023 (-45.1%), $9.11 million in FY2022 (-41.7%) and $15.63 million in FY2021.
- Five-year quarterly Cash & Equivalents spans a low of $4.19 million in fiscal Q4 2024 and a high of $225.83 million in fiscal Q2 2026.
- Year over year, Cash & Equivalents has now increased in each of the last three quarters, with growth averaging 465.0% over the last seven quarters.
- The high point for year-over-year Cash & Equivalents in five years was fiscal Q2 2025 (growth of 781.4%); the low point was fiscal Q3 2022 (a decline of 62.1%).
- Per Business Quant data, the three fiscal quarters before Q3 2026 came in at $225.83 million (Q2 2026), $63.86 million (Q1 2026) and $60.24 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Bright Minds Biosciences | 400.73 Mn | -162.86 Mn | - | 216.64 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 216.64 Mn |
| Mar 31, 2026 | 222.35 Mn |
| Dec 31, 2025 | 65.02 Mn |
| Sep 30, 2025 | 59.58 Mn |
| Jun 30, 2025 | 37.56 Mn |
| Mar 31, 2025 | 38.91 Mn |
| Dec 31, 2024 | 40.35 Mn |
| Sep 30, 2024 | 4.23 Mn |
| Jun 30, 2024 | 4.52 Mn |
| Mar 31, 2024 | 4.38 Mn |
| Dec 31, 2023 | 5.11 Mn |
| Sep 30, 2023 | 5.00 Mn |
| Jun 30, 2023 | 6.14 Mn |
| Mar 31, 2023 | 7.15 Mn |
| Dec 31, 2022 | 8.27 Mn |
| Sep 30, 2022 | 8.50 Mn |
| Jun 30, 2022 | 6.71 Mn |
| Mar 31, 2022 | 9.19 Mn |
| Dec 31, 2021 | 11.86 Mn |
| Sep 30, 2021 | 15.49 Mn |
API Access
Bright Minds Biosciences Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=DRUG&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "DRUG", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=DRUG&period=max&api_key=YOUR_API_KEY");
const data = await res.json();